Exact Sciences Corp (EXAS)
53.07
+0.37
(+0.70%)
USD |
NASDAQ |
Nov 21, 16:00
53.08
+0.01
(+0.02%)
After-Hours: 20:00
Exact Sciences Revenue (Quarterly): 708.66M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 708.66M |
| June 30, 2024 | 699.26M |
| March 31, 2024 | 637.52M |
| December 31, 2023 | 646.88M |
| September 30, 2023 | 628.34M |
| June 30, 2023 | 622.09M |
| March 31, 2023 | 602.45M |
| December 31, 2022 | 553.00M |
| September 30, 2022 | 523.07M |
| June 30, 2022 | 521.64M |
| March 31, 2022 | 486.57M |
| December 31, 2021 | 473.81M |
| September 30, 2021 | 456.38M |
| June 30, 2021 | 434.82M |
| March 31, 2021 | 402.08M |
| December 31, 2020 | 466.34M |
| September 30, 2020 | 408.36M |
| June 30, 2020 | 268.87M |
| March 31, 2020 | 347.82M |
| December 31, 2019 | 295.58M |
| September 30, 2019 | 218.80M |
| June 30, 2019 | 199.87M |
| March 31, 2019 | 162.04M |
| December 31, 2018 | 142.98M |
| September 30, 2018 | 118.29M |
| Date | Value |
|---|---|
| June 30, 2018 | 102.89M |
| March 31, 2018 | 90.30M |
| December 31, 2017 | 87.41M |
| September 30, 2017 | 72.57M |
| June 30, 2017 | 57.65M |
| March 31, 2017 | 48.36M |
| December 31, 2016 | 35.24M |
| September 30, 2016 | 28.12M |
| June 30, 2016 | 21.18M |
| March 31, 2016 | 14.84M |
| December 31, 2015 | 14.42M |
| September 30, 2015 | 12.63M |
| June 30, 2015 | 8.119M |
| March 31, 2015 | 4.266M |
| December 31, 2014 | 1.504M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 0.294M |
| December 31, 2013 | 1.036M |
| September 30, 2013 | 1.036M |
| June 30, 2013 | 1.036M |
| March 31, 2013 | 1.036M |
| December 31, 2012 | 1.036M |
| September 30, 2012 | 1.036M |
| June 30, 2012 | 1.036M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
268.87M
Minimum
Jun 2020
708.66M
Maximum
Sep 2024
509.18M
Average
504.11M
Median
Revenue (Quarterly) Benchmarks
| Quest Diagnostics Inc | 2.488B |
| Illumina Inc | 1.08B |
| Guardant Health Inc | 191.48M |
| Delcath Systems Inc | 11.20M |
| Progyny Inc | 286.62M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.24M |
| Total Expenses (Quarterly) | 729.44M |
| EPS Diluted (Quarterly) | -0.21 |
| Enterprise Value | 11.37B |
| Gross Profit Margin (Quarterly) | 72.33% |
| Profit Margin (Quarterly) | -5.40% |
| Earnings Yield | -2.20% |
| Normalized Earnings Yield | -2.452 |